Demystifying DEA's Role in MAT Regulation & Implementing a Zero Risk Program

Date: December 16, 2019, 12-1PM.

Featured Speaker: Dennis A. Wichern

Note: Registering here will allow you to attend any of our future sessions. You can cancel your registration at any time.

Description: This one-hour web training will provide an overview of the authority of the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), and Substance Abuse and Mental Health Services Administration (SAMHSA) as it relates to regulating the use of medications in the provision of treatment for opioid use disorders (OUD), along with a review of national studies, risk mitigation strategies, case studies, emerging issues, commonly asked questions, and strategies for preventing a DEA audit. The goal of the training session is to alleviate provider concerns relative to operating a MAT medical practice.

Continuing Medical Education and Continuing Education (CME/CE) credit offered at no cost!

For more information, contact Cfrable@mednet.ucla.edu

Starting Treatment: Buprenorphine Induction 101

Date: January 14, 2020, 12-1PM.

Featured Speaker: Candy Stockton, MD

Note: Registering here will allow you to attend any of our future sessions. You can cancel your registration at any time.

Description: This one-hour web training will provide an overview of best practices on how to start buprenorphine treatment for opioid use disorder in a variety of settings, including hospitals, emergency department, and office-based settings. The presenter will also cover safe home induction protocols and other recommendations.

Continuing Medical Education and Continuing Education (CME/CE) credit offered at no cost!

For more information, contact Cfrable@mednet.ucla.edu